fanta.bio Sample: CNhs12232
11856 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 676 / 15643 (4.3%) | 552 / 156430 (0.4%) | −324.0 | −324.0 | 12.25 |
| Eomes SRX4904815 | Natural killer cells Blood | 4024 / 15643 (25.7%) | 3770 / 156430 (2.4%) | −324.0 | −324.0 | 10.67 |
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2905 / 15643 (18.6%) | 2836 / 156430 (1.8%) | −324.0 | −324.0 | 10.24 |
| Epitope tags SRX13233372 | Testis Gonad | 1374 / 15643 (8.8%) | 1416 / 156430 (0.9%) | −324.0 | −324.0 | 9.70 |
| Ikzf1 SRX8994273 | B cells Blood | 795 / 15643 (5.1%) | 1032 / 156430 (0.7%) | −324.0 | −324.0 | 7.70 |
| Ikzf1 SRX8994275 | B cells Blood | 849 / 15643 (5.4%) | 1117 / 156430 (0.7%) | −324.0 | −324.0 | 7.60 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 1070 / 15643 (6.8%) | 1471 / 156430 (0.9%) | −324.0 | −324.0 | 7.27 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 891 / 15643 (5.7%) | 1226 / 156430 (0.8%) | −324.0 | −324.0 | 7.27 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 967 / 15643 (6.2%) | 1344 / 156430 (0.9%) | −324.0 | −324.0 | 7.19 |
| Ikzf1 SRX8994274 | B cells Blood | 1077 / 15643 (6.9%) | 1501 / 156430 (1.0%) | −324.0 | −324.0 | 7.18 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1270 / 15643 (8.1%) | 1774 / 156430 (1.1%) | −324.0 | −324.0 | 7.16 |
| Ikzf1 SRX8994276 | B cells Blood | 890 / 15643 (5.7%) | 1264 / 156430 (0.8%) | −324.0 | −324.0 | 7.04 |
| Epitope tags SRX10239037 | Natural killer cells Blood | 923 / 15643 (5.9%) | 1343 / 156430 (0.9%) | −324.0 | −324.0 | 6.87 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 966 / 15643 (6.2%) | 1408 / 156430 (0.9%) | −324.0 | −324.0 | 6.86 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 972 / 15643 (6.2%) | 1452 / 156430 (0.9%) | −324.0 | −324.0 | 6.69 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 1063 / 15643 (6.8%) | 1603 / 156430 (1.0%) | −324.0 | −324.0 | 6.63 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 959 / 15643 (6.1%) | 1479 / 156430 (0.9%) | −324.0 | −324.0 | 6.48 |
| Brd4 SRX8934800 | B cells Blood | 1014 / 15643 (6.5%) | 1613 / 156430 (1.0%) | −324.0 | −324.0 | 6.29 |
| Brd4 SRX8934799 | B cells Blood | 1306 / 15643 (8.3%) | 2089 / 156430 (1.3%) | −324.0 | −324.0 | 6.25 |
| Med12 SRX5086062 | Th2 Cells Blood | 932 / 15643 (6.0%) | 1503 / 156430 (1.0%) | −324.0 | −324.0 | 6.20 |
| Rag1 SRX1046534 | Thymocytes Blood | 1573 / 15643 (10.1%) | 2543 / 156430 (1.6%) | −324.0 | −324.0 | 6.19 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 1038 / 15643 (6.6%) | 1721 / 156430 (1.1%) | −324.0 | −324.0 | 6.03 |
| Runx1 SRX7821112 | Hematopoietic progenitors Blood | 1264 / 15643 (8.1%) | 2146 / 156430 (1.4%) | −324.0 | −324.0 | 5.89 |
| Runx1 SRX1939447 | Lymphoid-primed multipotent progenitors Blood | 1262 / 15643 (8.1%) | 2147 / 156430 (1.4%) | −324.0 | −324.0 | 5.88 |
| Med1 SRX206369 | Pro-B cells Blood | 1459 / 15643 (9.3%) | 2498 / 156430 (1.6%) | −324.0 | −324.0 | 5.84 |
| Runx3 SRX338019 | Natural killer cells Blood | 1213 / 15643 (7.8%) | 2081 / 156430 (1.3%) | −324.0 | −324.0 | 5.83 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1422 / 15643 (9.1%) | 2440 / 156430 (1.6%) | −324.0 | −324.0 | 5.83 |
| Rag2 SRX018807 | Thymocytes Blood | 1060 / 15643 (6.8%) | 1819 / 156430 (1.2%) | −324.0 | −324.0 | 5.83 |
| Brd4 SRX3113705 | CD4+ T cells Blood | 962 / 15643 (6.1%) | 1653 / 156430 (1.1%) | −324.0 | −324.0 | 5.82 |
| Ikzf1 SRX149204 | B3 Blood | 1080 / 15643 (6.9%) | 1858 / 156430 (1.2%) | −324.0 | −324.0 | 5.81 |
| Ets1 SRX1881674 | B cells Blood | 1441 / 15643 (9.2%) | 2488 / 156430 (1.6%) | −324.0 | −324.0 | 5.79 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1407 / 15643 (9.0%) | 2448 / 156430 (1.6%) | −324.0 | −324.0 | 5.75 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1202 / 15643 (7.7%) | 2097 / 156430 (1.3%) | −324.0 | −324.0 | 5.73 |
| Ets1 SRX1881673 | B cells Blood | 1454 / 15643 (9.3%) | 2544 / 156430 (1.6%) | −324.0 | −324.0 | 5.72 |
| Stat5a SRX2975355 | Natural killer cells Blood | 1049 / 15643 (6.7%) | 1848 / 156430 (1.2%) | −324.0 | −324.0 | 5.68 |
| Brd4 SRX10701688 | Spleen Spleen | 1186 / 15643 (7.6%) | 2093 / 156430 (1.3%) | −324.0 | −324.0 | 5.67 |
| Runx3 SRX338021 | Natural killer cells Blood | 964 / 15643 (6.2%) | 1719 / 156430 (1.1%) | −324.0 | −324.0 | 5.61 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 1215 / 15643 (7.8%) | 2175 / 156430 (1.4%) | −324.0 | −324.0 | 5.59 |
| Brd4 SRX1465788 | B cells Blood | 1626 / 15643 (10.4%) | 2912 / 156430 (1.9%) | −324.0 | −324.0 | 5.58 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1381 / 15643 (8.8%) | 2485 / 156430 (1.6%) | −324.0 | −324.0 | 5.56 |
| Ikzf1 SRX149203 | B3 Blood | 1205 / 15643 (7.7%) | 2169 / 156430 (1.4%) | −324.0 | −324.0 | 5.56 |
| Rag2 SRX018809 | Thymocytes Blood | 1409 / 15643 (9.0%) | 2539 / 156430 (1.6%) | −324.0 | −324.0 | 5.55 |
| Med12 SRX5086064 | Th2 Cells Blood | 1125 / 15643 (7.2%) | 2062 / 156430 (1.3%) | −324.0 | −324.0 | 5.46 |
| Nipbl SRX5730170 | B cells Blood | 1378 / 15643 (8.8%) | 2574 / 156430 (1.6%) | −324.0 | −324.0 | 5.35 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1897 / 15643 (12.1%) | 3553 / 156430 (2.3%) | −324.0 | −324.0 | 5.34 |
| Tbx21 SRX7726481 | Natural killer cells Blood | 1034 / 15643 (6.6%) | 1942 / 156430 (1.2%) | −324.0 | −324.0 | 5.32 |
| Runx1 SRX738259 | EML Blood | 1015 / 15643 (6.5%) | 1912 / 156430 (1.2%) | −324.0 | −324.0 | 5.31 |
| Med12 SRX5086065 | Th2 Cells Blood | 1173 / 15643 (7.5%) | 2213 / 156430 (1.4%) | −324.0 | −324.0 | 5.30 |
| Nipbl SRX5730168 | B cells Blood | 1398 / 15643 (8.9%) | 2642 / 156430 (1.7%) | −324.0 | −324.0 | 5.29 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 1183 / 15643 (7.6%) | 2237 / 156430 (1.4%) | −324.0 | −324.0 | 5.29 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1648 / 15643 (10.5%) | 3122 / 156430 (2.0%) | −324.0 | −324.0 | 5.28 |
| Ep300 SRX7726473 | Natural killer cells Blood | 1135 / 15643 (7.3%) | 2167 / 156430 (1.4%) | −324.0 | −324.0 | 5.24 |
| Epitope tags SRX3279733 | B cells Blood | 1861 / 15643 (11.9%) | 3564 / 156430 (2.3%) | −324.0 | −324.0 | 5.22 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1296 / 15643 (8.3%) | 2485 / 156430 (1.6%) | −324.0 | −324.0 | 5.22 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1366 / 15643 (8.7%) | 2628 / 156430 (1.7%) | −324.0 | −324.0 | 5.20 |
| Med12 SRX5086066 | Th2 Cells Blood | 1760 / 15643 (11.3%) | 3399 / 156430 (2.2%) | −324.0 | −324.0 | 5.18 |
| Bcl11a SRX8030787 | Acute myeloid leukemia Blood | 1238 / 15643 (7.9%) | 2407 / 156430 (1.5%) | −324.0 | −324.0 | 5.14 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1433 / 15643 (9.2%) | 2789 / 156430 (1.8%) | −324.0 | −324.0 | 5.14 |
| Fli1 SRX5958816 | Pro-B cells Blood | 1055 / 15643 (6.7%) | 2059 / 156430 (1.3%) | −324.0 | −324.0 | 5.12 |
| Epitope tags SRX24288473 | Pro-B cells Blood | 1182 / 15643 (7.6%) | 2307 / 156430 (1.5%) | −324.0 | −324.0 | 5.12 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1536 / 15643 (9.8%) | 3007 / 156430 (1.9%) | −324.0 | −324.0 | 5.11 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1535 / 15643 (9.8%) | 3009 / 156430 (1.9%) | −324.0 | −324.0 | 5.10 |
| Hdac1 SRX1815526 | B cells Blood | 1504 / 15643 (9.6%) | 2950 / 156430 (1.9%) | −324.0 | −324.0 | 5.10 |
| Bach2 SRX2200546 | Pro-B cells Blood | 2108 / 15643 (13.5%) | 4144 / 156430 (2.6%) | −324.0 | −324.0 | 5.09 |
| Runx1 SRX9633977 | B cells Blood | 1109 / 15643 (7.1%) | 2181 / 156430 (1.4%) | −324.0 | −324.0 | 5.08 |
| Nipbl SRX8694071 | B cells Blood | 1536 / 15643 (9.8%) | 3027 / 156430 (1.9%) | −324.0 | −324.0 | 5.07 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1626 / 15643 (10.4%) | 3213 / 156430 (2.1%) | −324.0 | −324.0 | 5.06 |
| Myc SRX5356999 | Naive B cells Blood | 1691 / 15643 (10.8%) | 3363 / 156430 (2.1%) | −324.0 | −324.0 | 5.03 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1528 / 15643 (9.8%) | 3040 / 156430 (1.9%) | −324.0 | −324.0 | 5.03 |
| Bcl11b SRX2880138 | Thymocytes Blood | 1122 / 15643 (7.2%) | 2246 / 156430 (1.4%) | −324.0 | −324.0 | 5.00 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1482 / 15643 (9.5%) | 2970 / 156430 (1.9%) | −324.0 | −324.0 | 4.99 |
| Fli1 SRX1056338 | 416B Blood | 1513 / 15643 (9.7%) | 3048 / 156430 (1.9%) | −324.0 | −324.0 | 4.96 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1313 / 15643 (8.4%) | 2652 / 156430 (1.7%) | −324.0 | −324.0 | 4.95 |
| Brd4 SRX10701687 | Spleen Spleen | 1504 / 15643 (9.6%) | 3039 / 156430 (1.9%) | −324.0 | −324.0 | 4.95 |
| Bcl11b SRX1677236 | Thymus Blood | 1155 / 15643 (7.4%) | 2336 / 156430 (1.5%) | −324.0 | −324.0 | 4.94 |
| Myc SRX353782 | B cells Blood | 1250 / 15643 (8.0%) | 2536 / 156430 (1.6%) | −324.0 | −324.0 | 4.93 |
| Kat2a SRX1815524 | B cells Blood | 1519 / 15643 (9.7%) | 3083 / 156430 (2.0%) | −324.0 | −324.0 | 4.93 |
| Rag2 SRX1046543 | Thymocytes Blood | 2349 / 15643 (15.0%) | 4819 / 156430 (3.1%) | −324.0 | −324.0 | 4.87 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1462 / 15643 (9.3%) | 3006 / 156430 (1.9%) | −324.0 | −324.0 | 4.86 |
| Nipbl SRX5730166 | B cells Blood | 1883 / 15643 (12.0%) | 3872 / 156430 (2.5%) | −324.0 | −324.0 | 4.86 |
| Ep300 SRX7726474 | Natural killer cells Blood | 1416 / 15643 (9.1%) | 2925 / 156430 (1.9%) | −324.0 | −324.0 | 4.84 |
| Erg SRX310200 | Mast Cells Blood | 1750 / 15643 (11.2%) | 3616 / 156430 (2.3%) | −324.0 | −324.0 | 4.84 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1411 / 15643 (9.0%) | 2922 / 156430 (1.9%) | −324.0 | −324.0 | 4.83 |
| Brd4 SRX7799914 | CH12 Blood | 2000 / 15643 (12.8%) | 4145 / 156430 (2.6%) | −324.0 | −324.0 | 4.83 |
| Brd4 SRX3602879 | iPS cells Pluripotent stem cell | 1142 / 15643 (7.3%) | 2375 / 156430 (1.5%) | −324.0 | −324.0 | 4.81 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1591 / 15643 (10.2%) | 3328 / 156430 (2.1%) | −324.0 | −324.0 | 4.78 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1882 / 15643 (12.0%) | 3941 / 156430 (2.5%) | −324.0 | −324.0 | 4.78 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1836 / 15643 (11.7%) | 3850 / 156430 (2.5%) | −324.0 | −324.0 | 4.77 |
| Kmt2a SRX17605412 | Leukemia Blood | 1680 / 15643 (10.7%) | 3533 / 156430 (2.3%) | −324.0 | −324.0 | 4.76 |
| Nipbl SRX8694068 | B cells Blood | 1679 / 15643 (10.7%) | 3531 / 156430 (2.3%) | −324.0 | −324.0 | 4.76 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1794 / 15643 (11.5%) | 3778 / 156430 (2.4%) | −324.0 | −324.0 | 4.75 |
| Crebbp SRX25655380 | Leukemia Blood | 1159 / 15643 (7.4%) | 2450 / 156430 (1.6%) | −324.0 | −324.0 | 4.73 |
| Bcl11b SRX1677234 | Thymus Blood | 2368 / 15643 (15.1%) | 5006 / 156430 (3.2%) | −324.0 | −324.0 | 4.73 |
| Epitope tags SRX3219118 | RN2 Blood | 1604 / 15643 (10.3%) | 3391 / 156430 (2.2%) | −324.0 | −324.0 | 4.73 |
| Kmt2a SRX11002576 | Leukemia Blood | 1294 / 15643 (8.3%) | 2745 / 156430 (1.8%) | −324.0 | −324.0 | 4.71 |
| Foxp3 SRX3829344 | Treg Blood | 1279 / 15643 (8.2%) | 2716 / 156430 (1.7%) | −324.0 | −324.0 | 4.71 |
| Nipbl SRX8694069 | B cells Blood | 1810 / 15643 (11.6%) | 3851 / 156430 (2.5%) | −324.0 | −324.0 | 4.70 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 2259 / 15643 (14.4%) | 4821 / 156430 (3.1%) | −324.0 | −324.0 | 4.69 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3648 / 15643 (23.3%) | 7791 / 156430 (5.0%) | −324.0 | −324.0 | 4.68 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1422 / 15643 (9.1%) | 3040 / 156430 (1.9%) | −324.0 | −324.0 | 4.68 |
| Men1 SRX415268 | Th2 Cells Blood | 1255 / 15643 (8.0%) | 2686 / 156430 (1.7%) | −324.0 | −324.0 | 4.67 |
| Pou2f1 SRX7368547 | B cells Blood | 1250 / 15643 (8.0%) | 2677 / 156430 (1.7%) | −324.0 | −324.0 | 4.67 |
| Pou2f1 SRX7368548 | B cells Blood | 1273 / 15643 (8.1%) | 2728 / 156430 (1.7%) | −324.0 | −324.0 | 4.67 |
| Runx1 SRX1892675 | 416B Blood | 1179 / 15643 (7.5%) | 2533 / 156430 (1.6%) | −324.0 | −324.0 | 4.65 |
| Med12 SRX5086068 | Th2 Cells Blood | 1655 / 15643 (10.6%) | 3578 / 156430 (2.3%) | −324.0 | −324.0 | 4.63 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1973 / 15643 (12.6%) | 4273 / 156430 (2.7%) | −324.0 | −324.0 | 4.62 |
| Hdac1 SRX7726757 | B cells Blood | 1278 / 15643 (8.2%) | 2768 / 156430 (1.8%) | −324.0 | −324.0 | 4.62 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1566 / 15643 (10.0%) | 3394 / 156430 (2.2%) | −324.0 | −324.0 | 4.61 |
| Bcl11b SRX2880136 | CD4+ T cells Blood | 1249 / 15643 (8.0%) | 2707 / 156430 (1.7%) | −324.0 | −324.0 | 4.61 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1903 / 15643 (12.2%) | 4129 / 156430 (2.6%) | −324.0 | −324.0 | 4.61 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1642 / 15643 (10.5%) | 3574 / 156430 (2.3%) | −324.0 | −324.0 | 4.59 |
| Runx1 DRX165596 | Unclassified Unclassified | 1574 / 15643 (10.1%) | 3429 / 156430 (2.2%) | −324.0 | −324.0 | 4.59 |
| Runx1 SRX5358496 | Pro-B cells Blood | 3202 / 15643 (20.5%) | 6976 / 156430 (4.5%) | −324.0 | −324.0 | 4.59 |
| Nipbl SRX8694070 | B cells Blood | 1647 / 15643 (10.5%) | 3599 / 156430 (2.3%) | −324.0 | −324.0 | 4.58 |
| Runx1 SRX1438366 | EML Blood | 2726 / 15643 (17.4%) | 5959 / 156430 (3.8%) | −324.0 | −324.0 | 4.57 |
| Ets1 SRX5086094 | Th2 Cells Blood | 2436 / 15643 (15.6%) | 5344 / 156430 (3.4%) | −324.0 | −324.0 | 4.56 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1508 / 15643 (9.6%) | 3315 / 156430 (2.1%) | −324.0 | −324.0 | 4.55 |
| Nelfb SRX11921266 | Naive T cells Blood | 1276 / 15643 (8.2%) | 2809 / 156430 (1.8%) | −324.0 | −324.0 | 4.54 |
| Myc SRX5356998 | Naive B cells Blood | 2145 / 15643 (13.7%) | 4730 / 156430 (3.0%) | −324.0 | −324.0 | 4.53 |
| Bcor SRX22719795 | Leukemia Blood | 1714 / 15643 (11.0%) | 3783 / 156430 (2.4%) | −324.0 | −324.0 | 4.53 |
| Men1 SRX11858935 | Leukemia Blood | 1225 / 15643 (7.8%) | 2705 / 156430 (1.7%) | −324.0 | −324.0 | 4.53 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1868 / 15643 (11.9%) | 4133 / 156430 (2.6%) | −324.0 | −324.0 | 4.52 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 2178 / 15643 (13.9%) | 4819 / 156430 (3.1%) | −324.0 | −324.0 | 4.52 |
| Spi1 SRX5026209 | Mast Cells Blood | 1369 / 15643 (8.8%) | 3038 / 156430 (1.9%) | −324.0 | −324.0 | 4.51 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2394 / 15643 (15.3%) | 5321 / 156430 (3.4%) | −324.0 | −324.0 | 4.50 |
| Hdac1 SRX7726758 | B cells Blood | 1758 / 15643 (11.2%) | 3911 / 156430 (2.5%) | −324.0 | −324.0 | 4.50 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1969 / 15643 (12.6%) | 4413 / 156430 (2.8%) | −324.0 | −324.0 | 4.46 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 2143 / 15643 (13.7%) | 4820 / 156430 (3.1%) | −324.0 | −324.0 | 4.45 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1785 / 15643 (11.4%) | 4025 / 156430 (2.6%) | −324.0 | −324.0 | 4.43 |
| Ikzf3 SRX10166892 | Thymocytes Blood | 1190 / 15643 (7.6%) | 2684 / 156430 (1.7%) | −324.0 | −324.0 | 4.43 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1603 / 15643 (10.2%) | 3616 / 156430 (2.3%) | −324.0 | −324.0 | 4.43 |
| Nipbl SRX8694067 | B cells Blood | 1912 / 15643 (12.2%) | 4333 / 156430 (2.8%) | −324.0 | −324.0 | 4.41 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1780 / 15643 (11.4%) | 4041 / 156430 (2.6%) | −324.0 | −324.0 | 4.40 |
| Bach2 SRX2200545 | Pro-B cells Blood | 2274 / 15643 (14.5%) | 5175 / 156430 (3.3%) | −324.0 | −324.0 | 4.39 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1778 / 15643 (11.4%) | 4053 / 156430 (2.6%) | −324.0 | −324.0 | 4.39 |
| Myc SRX5357000 | Naive B cells Blood | 2003 / 15643 (12.8%) | 4571 / 156430 (2.9%) | −324.0 | −324.0 | 4.38 |
| Ep300 SRX1815530 | B cells Blood | 1384 / 15643 (8.8%) | 3160 / 156430 (2.0%) | −324.0 | −324.0 | 4.38 |
| Tcf3 SRX1568865 | Unclassified Unclassified | 1448 / 15643 (9.3%) | 3312 / 156430 (2.1%) | −324.0 | −324.0 | 4.37 |
| Epitope tags SRX3279734 | B cells Blood | 2856 / 15643 (18.3%) | 6539 / 156430 (4.2%) | −324.0 | −324.0 | 4.37 |
| Ets1 SRX5086099 | Th2 Cells Blood | 2328 / 15643 (14.9%) | 5337 / 156430 (3.4%) | −324.0 | −324.0 | 4.36 |
| Kdm2b SRX22719856 | Leukemia Blood | 1958 / 15643 (12.5%) | 4491 / 156430 (2.9%) | −324.0 | −324.0 | 4.36 |
| Bcl11b SRX1649982 | Thymus Blood | 2528 / 15643 (16.2%) | 5802 / 156430 (3.7%) | −324.0 | −324.0 | 4.36 |
| Myc SRX353784 | B cells Blood | 2030 / 15643 (13.0%) | 4676 / 156430 (3.0%) | −324.0 | −324.0 | 4.34 |
| Nipbl SRX4895107 | CH12 Blood | 1877 / 15643 (12.0%) | 4335 / 156430 (2.8%) | −324.0 | −324.0 | 4.33 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 2023 / 15643 (12.9%) | 4683 / 156430 (3.0%) | −324.0 | −324.0 | 4.32 |
| N6amt1 SRX8338674 | Tumour organoids Others | 1329 / 15643 (8.5%) | 3081 / 156430 (2.0%) | −324.0 | −324.0 | 4.31 |
| Tmem131 SRX3219121 | RN2 Blood | 1556 / 15643 (9.9%) | 3608 / 156430 (2.3%) | −324.0 | −324.0 | 4.31 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1951 / 15643 (12.5%) | 4529 / 156430 (2.9%) | −324.0 | −324.0 | 4.31 |
| Rag2 SRX1046550 | B cells Blood | 2944 / 15643 (18.8%) | 6850 / 156430 (4.4%) | −324.0 | −324.0 | 4.30 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1733 / 15643 (11.1%) | 4040 / 156430 (2.6%) | −324.0 | −324.0 | 4.29 |
| Rag2 SRX1046552 | B cells Blood | 2636 / 15643 (16.9%) | 6149 / 156430 (3.9%) | −324.0 | −324.0 | 4.29 |
| Rad21 SRX7508562 | Pro-B cells Blood | 1389 / 15643 (8.9%) | 3244 / 156430 (2.1%) | −324.0 | −324.0 | 4.28 |
| Pax5 SRX19312223 | Pro-B cells Blood | 2083 / 15643 (13.3%) | 4869 / 156430 (3.1%) | −324.0 | −324.0 | 4.28 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1845 / 15643 (11.8%) | 4315 / 156430 (2.8%) | −324.0 | −324.0 | 4.28 |
| Tet2 SRX4232706 | Hematopoietic cells Blood | 1387 / 15643 (8.9%) | 3248 / 156430 (2.1%) | −324.0 | −324.0 | 4.27 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2545 / 15643 (16.3%) | 5976 / 156430 (3.8%) | −324.0 | −324.0 | 4.26 |
| Spi1 SRX5026213 | Mast Cells Blood | 1567 / 15643 (10.0%) | 3683 / 156430 (2.4%) | −324.0 | −324.0 | 4.25 |
| Ep300 SRX25655383 | Leukemia Blood | 1839 / 15643 (11.8%) | 4325 / 156430 (2.8%) | −324.0 | −324.0 | 4.25 |
| Pcgf1 DRX053276 | MEL Blood | 1314 / 15643 (8.4%) | 3099 / 156430 (2.0%) | −324.0 | −324.0 | 4.24 |
| Bcl11b SRX1677239 | Thymus Blood | 2474 / 15643 (15.8%) | 5838 / 156430 (3.7%) | −324.0 | −324.0 | 4.24 |
| Nipbl SRX8694065 | B cells Blood | 2406 / 15643 (15.4%) | 5696 / 156430 (3.6%) | −324.0 | −324.0 | 4.22 |
| Med23 SRX20509321 | CH12 Blood | 1643 / 15643 (10.5%) | 3890 / 156430 (2.5%) | −324.0 | −324.0 | 4.22 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2901 / 15643 (18.5%) | 6869 / 156430 (4.4%) | −324.0 | −324.0 | 4.22 |
| Nipbl SRX5730169 | B cells Blood | 1786 / 15643 (11.4%) | 4231 / 156430 (2.7%) | −324.0 | −324.0 | 4.22 |
| Nipbl SRX5730164 | CH12F3 Blood | 1677 / 15643 (10.7%) | 3977 / 156430 (2.5%) | −324.0 | −324.0 | 4.22 |
| GFP SRX2486160 | C127 Breast | 1708 / 15643 (10.9%) | 4055 / 156430 (2.6%) | −324.0 | −324.0 | 4.21 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 2061 / 15643 (13.2%) | 4909 / 156430 (3.1%) | −324.0 | −324.0 | 4.20 |
| Satb1 SRX2379961 | Thymocytes Blood | 1397 / 15643 (8.9%) | 3330 / 156430 (2.1%) | −324.0 | −324.0 | 4.20 |
| Nipbl SRX8694063 | T cells Blood | 2386 / 15643 (15.3%) | 5690 / 156430 (3.6%) | −324.0 | −324.0 | 4.19 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 2066 / 15643 (13.2%) | 4932 / 156430 (3.2%) | −324.0 | −324.0 | 4.19 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 2055 / 15643 (13.1%) | 4911 / 156430 (3.1%) | −324.0 | −324.0 | 4.18 |
| Runx1 SRX1438367 | EML Blood | 3077 / 15643 (19.7%) | 7361 / 156430 (4.7%) | −324.0 | −324.0 | 4.18 |
| Spi1 SRX5026212 | Mast Cells Blood | 1633 / 15643 (10.4%) | 3909 / 156430 (2.5%) | −324.0 | −324.0 | 4.18 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2720 / 15643 (17.4%) | 6541 / 156430 (4.2%) | −324.0 | −324.0 | 4.16 |
| Epitope tags SRX3219125 | RN2 Blood | 1638 / 15643 (10.5%) | 3945 / 156430 (2.5%) | −324.0 | −324.0 | 4.15 |
| Spi1 SRX1465791 | B cells Blood | 1623 / 15643 (10.4%) | 3910 / 156430 (2.5%) | −324.0 | −324.0 | 4.15 |
| Nipbl SRX5730171 | B cells Blood | 1830 / 15643 (11.7%) | 4409 / 156430 (2.8%) | −324.0 | −324.0 | 4.15 |
| Myc SRX353783 | B cells Blood | 2614 / 15643 (16.7%) | 6307 / 156430 (4.0%) | −324.0 | −324.0 | 4.14 |
| Nipbl SRX8694066 | B cells Blood | 1879 / 15643 (12.0%) | 4534 / 156430 (2.9%) | −324.0 | −324.0 | 4.14 |
| Smarcc1 SRX8673307 | Tumor Others | 1343 / 15643 (8.6%) | 3245 / 156430 (2.1%) | −324.0 | −324.0 | 4.14 |
| Spi1 SRX2499694 | Scid.adh.2c2 Blood | 1428 / 15643 (9.1%) | 3462 / 156430 (2.2%) | −324.0 | −324.0 | 4.12 |
| Brd4 SRX7799919 | CH12 Blood | 2533 / 15643 (16.2%) | 6148 / 156430 (3.9%) | −324.0 | −324.0 | 4.12 |
| Nipbl SRX3753617 | B cells Blood | 2395 / 15643 (15.3%) | 5818 / 156430 (3.7%) | −324.0 | −324.0 | 4.12 |
| Brd4 SRX3602867 | iPS cells Pluripotent stem cell | 1358 / 15643 (8.7%) | 3299 / 156430 (2.1%) | −324.0 | −324.0 | 4.12 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1412 / 15643 (9.0%) | 3434 / 156430 (2.2%) | −324.0 | −324.0 | 4.11 |
| Kmt2a SRX25655412 | Leukemia Blood | 1418 / 15643 (9.1%) | 3449 / 156430 (2.2%) | −324.0 | −324.0 | 4.11 |
| Runx3 SRX8718717 | T progenitor cells Blood | 2369 / 15643 (15.1%) | 5768 / 156430 (3.7%) | −324.0 | −324.0 | 4.11 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 3302 / 15643 (21.1%) | 8041 / 156430 (5.1%) | −324.0 | −324.0 | 4.11 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2512 / 15643 (16.1%) | 6129 / 156430 (3.9%) | −324.0 | −324.0 | 4.10 |
| Spi1 SRX5026211 | Mast Cells Blood | 1808 / 15643 (11.6%) | 4416 / 156430 (2.8%) | −324.0 | −324.0 | 4.09 |
| Rag2 SRX1046542 | Thymocytes Blood | 3037 / 15643 (19.4%) | 7419 / 156430 (4.7%) | −324.0 | −324.0 | 4.09 |
| Nipbl SRX5730167 | B cells Blood | 1747 / 15643 (11.2%) | 4271 / 156430 (2.7%) | −324.0 | −324.0 | 4.09 |
| Mta2 SRX3660791 | Scid.adh.2c2 Blood | 1312 / 15643 (8.4%) | 3208 / 156430 (2.1%) | −324.0 | −324.0 | 4.09 |
| Pax5 SRX19312225 | Pro-B cells Blood | 2120 / 15643 (13.6%) | 5185 / 156430 (3.3%) | −324.0 | −324.0 | 4.09 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2618 / 15643 (16.7%) | 6407 / 156430 (4.1%) | −324.0 | −324.0 | 4.09 |
| Hdac1 SRX7726755 | B cells Blood | 2089 / 15643 (13.4%) | 5114 / 156430 (3.3%) | −324.0 | −324.0 | 4.08 |
| Kmt2a SRX22719786 | Leukemia Blood | 1579 / 15643 (10.1%) | 3866 / 156430 (2.5%) | −324.0 | −324.0 | 4.08 |
| Runx1 SRX1892672 | 416B Blood | 1345 / 15643 (8.6%) | 3301 / 156430 (2.1%) | −324.0 | −324.0 | 4.07 |
| Runx1 SRX1892676 | 416B Blood | 1405 / 15643 (9.0%) | 3452 / 156430 (2.2%) | −324.0 | −324.0 | 4.07 |
| Irf4 SRX1131942 | Plasmablasts Blood | 1473 / 15643 (9.4%) | 3621 / 156430 (2.3%) | −324.0 | −324.0 | 4.07 |
| Ep300 SRX392764 | HAFTL Blood | 1306 / 15643 (8.3%) | 3213 / 156430 (2.1%) | −324.0 | −324.0 | 4.06 |
| Runx1 SRX5358492 | Pro-B cells Blood | 3636 / 15643 (23.2%) | 8950 / 156430 (5.7%) | −324.0 | −324.0 | 4.06 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1742 / 15643 (11.1%) | 4288 / 156430 (2.7%) | −324.0 | −324.0 | 4.06 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 2121 / 15643 (13.6%) | 5229 / 156430 (3.3%) | −324.0 | −324.0 | 4.06 |
| Men1 SRX415267 | Th2 Cells Blood | 1737 / 15643 (11.1%) | 4287 / 156430 (2.7%) | −324.0 | −324.0 | 4.05 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1466 / 15643 (9.4%) | 3621 / 156430 (2.3%) | −324.0 | −324.0 | 4.05 |
| Wdr5 SRX1815529 | B cells Blood | 2074 / 15643 (13.3%) | 5136 / 156430 (3.3%) | −324.0 | −324.0 | 4.04 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1640 / 15643 (10.5%) | 4062 / 156430 (2.6%) | −324.0 | −324.0 | 4.04 |
| Kmt2a SRX25655413 | Leukemia Blood | 1599 / 15643 (10.2%) | 3961 / 156430 (2.5%) | −324.0 | −324.0 | 4.04 |
| Cbfb SRX2389673 | Thymocytes Blood | 2425 / 15643 (15.5%) | 6009 / 156430 (3.8%) | −324.0 | −324.0 | 4.04 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 2321 / 15643 (14.8%) | 5767 / 156430 (3.7%) | −324.0 | −324.0 | 4.02 |
| Biotin SRX5578683 | ES cells Pluripotent stem cell | 1311 / 15643 (8.4%) | 3261 / 156430 (2.1%) | −324.0 | −324.0 | 4.02 |
| Bcor SRX22719796 | Leukemia Blood | 2349 / 15643 (15.0%) | 5843 / 156430 (3.7%) | −324.0 | −324.0 | 4.02 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1646 / 15643 (10.5%) | 4098 / 156430 (2.6%) | −324.0 | −324.0 | 4.02 |
| Tet2 SRX1387481 | MEL Blood | 1499 / 15643 (9.6%) | 3734 / 156430 (2.4%) | −324.0 | −324.0 | 4.01 |
| Spi1 SRX5026214 | Mast Cells Blood | 1793 / 15643 (11.5%) | 4469 / 156430 (2.9%) | −324.0 | −324.0 | 4.01 |
| Crebbp SRX25655381 | Leukemia Blood | 2230 / 15643 (14.3%) | 5561 / 156430 (3.6%) | −324.0 | −324.0 | 4.01 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 2334 / 15643 (14.9%) | 5823 / 156430 (3.7%) | −324.0 | −324.0 | 4.01 |
| Kmt2a SRX17605411 | Leukemia Blood | 2537 / 15643 (16.2%) | 6331 / 156430 (4.0%) | −324.0 | −324.0 | 4.01 |
| Fli1 SRX310201 | Mast Cells Blood | 2217 / 15643 (14.2%) | 5539 / 156430 (3.5%) | −324.0 | −324.0 | 4.00 |
| Myc SRX353785 | B cells Blood | 2617 / 15643 (16.7%) | 6557 / 156430 (4.2%) | −324.0 | −324.0 | 3.99 |
| Nipbl SRX2755276 | B cells Blood | 2684 / 15643 (17.2%) | 6732 / 156430 (4.3%) | −324.0 | −324.0 | 3.99 |
| Runx1 SRX5358488 | Pro-B cells Blood | 2180 / 15643 (13.9%) | 5469 / 156430 (3.5%) | −324.0 | −324.0 | 3.99 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1656 / 15643 (10.6%) | 4160 / 156430 (2.7%) | −324.0 | −324.0 | 3.98 |
| Spi1 SRX5026215 | Mast Cells Blood | 1876 / 15643 (12.0%) | 4736 / 156430 (3.0%) | −324.0 | −324.0 | 3.96 |
| Bcl11b SRX18851328 | Thymocytes Blood | 2426 / 15643 (15.5%) | 6125 / 156430 (3.9%) | −324.0 | −324.0 | 3.96 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1553 / 15643 (9.9%) | 3926 / 156430 (2.5%) | −324.0 | −324.0 | 3.96 |
| Elf1 SRX12734919 | Granulocyte-Macrophage Progenitor Cells Blood | 1390 / 15643 (8.9%) | 3515 / 156430 (2.2%) | −324.0 | −324.0 | 3.95 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1675 / 15643 (10.7%) | 4237 / 156430 (2.7%) | −324.0 | −324.0 | 3.95 |
| Rag2 SRX1046541 | Thymocytes Blood | 3163 / 15643 (20.2%) | 8002 / 156430 (5.1%) | −324.0 | −324.0 | 3.95 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2603 / 15643 (16.6%) | 6590 / 156430 (4.2%) | −324.0 | −324.0 | 3.95 |
| Spi1 SRX3729397 | Hematopoietic progenitors Blood | 1407 / 15643 (9.0%) | 3567 / 156430 (2.3%) | −324.0 | −324.0 | 3.94 |
| Runx1 SRX1892671 | 416B Blood | 1698 / 15643 (10.9%) | 4307 / 156430 (2.8%) | −324.0 | −324.0 | 3.94 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1986 / 15643 (12.7%) | 5047 / 156430 (3.2%) | −324.0 | −324.0 | 3.94 |
| Kdm1a SRX181863 | Granulocytes Blood | 1755 / 15643 (11.2%) | 4470 / 156430 (2.9%) | −324.0 | −324.0 | 3.93 |
| Nipbl SRX4895127 | CH12 Blood | 2755 / 15643 (17.6%) | 7032 / 156430 (4.5%) | −324.0 | −324.0 | 3.92 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1651 / 15643 (10.6%) | 4216 / 156430 (2.7%) | −324.0 | −324.0 | 3.92 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2851 / 15643 (18.2%) | 7289 / 156430 (4.7%) | −324.0 | −324.0 | 3.91 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1668 / 15643 (10.7%) | 4278 / 156430 (2.7%) | −324.0 | −324.0 | 3.90 |
| Nipbl SRX3753614 | B cells Blood | 1814 / 15643 (11.6%) | 4658 / 156430 (3.0%) | −324.0 | −324.0 | 3.89 |
| Pax5 SRX7809233 | Pro-B cells Blood | 1510 / 15643 (9.7%) | 3879 / 156430 (2.5%) | −324.0 | −324.0 | 3.89 |
| Runx3 SRX4677010 | Innate lymphoid cells Blood | 1509 / 15643 (9.6%) | 3882 / 156430 (2.5%) | −324.0 | −324.0 | 3.89 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 2241 / 15643 (14.3%) | 5768 / 156430 (3.7%) | −324.0 | −324.0 | 3.89 |
| Biotin SRX10950530 | Pro-B cells Blood | 1691 / 15643 (10.8%) | 4357 / 156430 (2.8%) | −324.0 | −324.0 | 3.88 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2895 / 15643 (18.5%) | 7462 / 156430 (4.8%) | −324.0 | −324.0 | 3.88 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1571 / 15643 (10.0%) | 4057 / 156430 (2.6%) | −324.0 | −324.0 | 3.87 |
| Rnf2 SRX9633976 | B cells Blood | 2322 / 15643 (14.8%) | 6000 / 156430 (3.8%) | −324.0 | −324.0 | 3.87 |
| Kdm2b SRX22719855 | Leukemia Blood | 2522 / 15643 (16.1%) | 6525 / 156430 (4.2%) | −324.0 | −324.0 | 3.87 |
| Kmt2a SRX25655409 | Leukemia Blood | 1387 / 15643 (8.9%) | 3590 / 156430 (2.3%) | −324.0 | −324.0 | 3.86 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1820 / 15643 (11.6%) | 4712 / 156430 (3.0%) | −324.0 | −324.0 | 3.86 |
| Rag2 SRX1046545 | Thymocytes Blood | 3270 / 15643 (20.9%) | 8483 / 156430 (5.4%) | −324.0 | −324.0 | 3.85 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2858 / 15643 (18.3%) | 7428 / 156430 (4.7%) | −324.0 | −324.0 | 3.85 |
| Kmt2a SRX25655410 | Leukemia Blood | 1484 / 15643 (9.5%) | 3857 / 156430 (2.5%) | −324.0 | −324.0 | 3.85 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1633 / 15643 (10.4%) | 4255 / 156430 (2.7%) | −324.0 | −324.0 | 3.84 |
| Rad21 SRX23052807 | mESC derived neural cells Pluripotent stem cell | 1406 / 15643 (9.0%) | 3672 / 156430 (2.3%) | −324.0 | −324.0 | 3.83 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2723 / 15643 (17.4%) | 7124 / 156430 (4.6%) | −324.0 | −324.0 | 3.82 |
| GFP SRX2486159 | C127 Breast | 2047 / 15643 (13.1%) | 5366 / 156430 (3.4%) | −324.0 | −324.0 | 3.81 |
| Nipbl SRX2755277 | B cells Blood | 3008 / 15643 (19.2%) | 7887 / 156430 (5.0%) | −324.0 | −324.0 | 3.81 |
| Kdm4b SRX7794503 | Mesenchymal stem cells Others | 1663 / 15643 (10.6%) | 4362 / 156430 (2.8%) | −324.0 | −324.0 | 3.81 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1951 / 15643 (12.5%) | 5119 / 156430 (3.3%) | −324.0 | −324.0 | 3.81 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2964 / 15643 (18.9%) | 7803 / 156430 (5.0%) | −324.0 | −324.0 | 3.80 |
| Med26 SRX20509320 | CH12 Blood | 2182 / 15643 (13.9%) | 5747 / 156430 (3.7%) | −324.0 | −324.0 | 3.80 |
| Hdac1 SRX7726756 | B cells Blood | 2226 / 15643 (14.2%) | 5883 / 156430 (3.8%) | −324.0 | −324.0 | 3.78 |
| Smad3 SRX14617681 | CH12 Blood | 1431 / 15643 (9.1%) | 3786 / 156430 (2.4%) | −324.0 | −324.0 | 3.78 |
| Wdr5 SRX1815515 | B cells Blood | 1926 / 15643 (12.3%) | 5107 / 156430 (3.3%) | −324.0 | −324.0 | 3.77 |
| Yy1 SRX14617702 | CH12 Blood | 1974 / 15643 (12.6%) | 5240 / 156430 (3.3%) | −324.0 | −324.0 | 3.77 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2759 / 15643 (17.6%) | 7329 / 156430 (4.7%) | −324.0 | −324.0 | 3.76 |
| Nipbl SRX3753616 | B cells Blood | 2844 / 15643 (18.2%) | 7562 / 156430 (4.8%) | −324.0 | −324.0 | 3.76 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 2055 / 15643 (13.1%) | 5479 / 156430 (3.5%) | −324.0 | −324.0 | 3.75 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2891 / 15643 (18.5%) | 7709 / 156430 (4.9%) | −324.0 | −324.0 | 3.75 |
| Stat4 SRX7726452 | Natural killer cells Blood | 1752 / 15643 (11.2%) | 4672 / 156430 (3.0%) | −324.0 | −324.0 | 3.75 |
| Nipbl SRX8694064 | T cells Blood | 2497 / 15643 (16.0%) | 6663 / 156430 (4.3%) | −324.0 | −324.0 | 3.75 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2715 / 15643 (17.4%) | 7245 / 156430 (4.6%) | −324.0 | −324.0 | 3.75 |
| Bcor SRX22719813 | Leukemia Blood | 1906 / 15643 (12.2%) | 5088 / 156430 (3.3%) | −324.0 | −324.0 | 3.75 |
| Runx1 SRX1892679 | 416B Blood | 1749 / 15643 (11.2%) | 4672 / 156430 (3.0%) | −324.0 | −324.0 | 3.74 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2384 / 15643 (15.2%) | 6373 / 156430 (4.1%) | −324.0 | −324.0 | 3.74 |
| Kmt2a SRX1815528 | B cells Blood | 3122 / 15643 (20.0%) | 8360 / 156430 (5.3%) | −324.0 | −324.0 | 3.73 |
| Hdac1 SRX1815525 | B cells Blood | 3302 / 15643 (21.1%) | 8845 / 156430 (5.7%) | −324.0 | −324.0 | 3.73 |
| Spi1 SRX5026216 | Mast Cells Blood | 2152 / 15643 (13.8%) | 5768 / 156430 (3.7%) | −324.0 | −324.0 | 3.73 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2974 / 15643 (19.0%) | 7989 / 156430 (5.1%) | −324.0 | −324.0 | 3.72 |
| Biotin SRX10950531 | Pro-B cells Blood | 1437 / 15643 (9.2%) | 3862 / 156430 (2.5%) | −324.0 | −324.0 | 3.72 |
| Hdac1 SRX9519542 | G1E Blood | 2211 / 15643 (14.1%) | 5944 / 156430 (3.8%) | −324.0 | −324.0 | 3.72 |
| Rnf2 SRX9633974 | B cells Blood | 2544 / 15643 (16.3%) | 6851 / 156430 (4.4%) | −324.0 | −324.0 | 3.71 |
| Rag2 SRX1046553 | B cells Blood | 3222 / 15643 (20.6%) | 8677 / 156430 (5.5%) | −324.0 | −324.0 | 3.71 |
| Tcf3 SRX1568859 | B cells Blood | 1834 / 15643 (11.7%) | 4947 / 156430 (3.2%) | −324.0 | −324.0 | 3.71 |
| Spi1 SRX7368553 | B cells Blood | 1503 / 15643 (9.6%) | 4055 / 156430 (2.6%) | −324.0 | −324.0 | 3.71 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3651 / 15643 (23.3%) | 9858 / 156430 (6.3%) | −324.0 | −324.0 | 3.70 |
| Nelfe SRX140395 | MEL Blood | 1646 / 15643 (10.5%) | 4456 / 156430 (2.8%) | −324.0 | −324.0 | 3.69 |
| Runx3 SRX8718740 | T progenitor cells Blood | 3117 / 15643 (19.9%) | 8443 / 156430 (5.4%) | −324.0 | −324.0 | 3.69 |
| Rnf2 SRX105448 | L8057 Blood | 1512 / 15643 (9.7%) | 4103 / 156430 (2.6%) | −324.0 | −324.0 | 3.69 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1689 / 15643 (10.8%) | 4591 / 156430 (2.9%) | −324.0 | −324.0 | 3.68 |
| Kmt2a SRX17605408 | Monocytes Blood | 1512 / 15643 (9.7%) | 4111 / 156430 (2.6%) | −324.0 | −324.0 | 3.68 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2884 / 15643 (18.4%) | 7842 / 156430 (5.0%) | −324.0 | −324.0 | 3.68 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2560 / 15643 (16.4%) | 6961 / 156430 (4.4%) | −324.0 | −324.0 | 3.68 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 2053 / 15643 (13.1%) | 5593 / 156430 (3.6%) | −324.0 | −324.0 | 3.67 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 2028 / 15643 (13.0%) | 5528 / 156430 (3.5%) | −324.0 | −324.0 | 3.67 |
| Fli1 SRX203227 | Megakaryocytes Blood | 1732 / 15643 (11.1%) | 4726 / 156430 (3.0%) | −324.0 | −324.0 | 3.66 |
| Batf SRX10150718 | CD8+ T cells Blood | 1824 / 15643 (11.7%) | 4979 / 156430 (3.2%) | −324.0 | −324.0 | 3.66 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1970 / 15643 (12.6%) | 5378 / 156430 (3.4%) | −324.0 | −324.0 | 3.66 |
| Nipbl SRX4895128 | CH12 Blood | 3094 / 15643 (19.8%) | 8478 / 156430 (5.4%) | −324.0 | −324.0 | 3.65 |
| Kmt2a SRX17605409 | Monocytes Blood | 1720 / 15643 (11.0%) | 4715 / 156430 (3.0%) | −324.0 | −324.0 | 3.65 |
| Cbfb SRX105447 | L8057 Blood | 1527 / 15643 (9.8%) | 4188 / 156430 (2.7%) | −324.0 | −324.0 | 3.65 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2536 / 15643 (16.2%) | 6958 / 156430 (4.4%) | −324.0 | −324.0 | 3.64 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1800 / 15643 (11.5%) | 4952 / 156430 (3.2%) | −324.0 | −324.0 | 3.63 |
| Ep300 SRX7726459 | Natural killer cells Blood | 2188 / 15643 (14.0%) | 6020 / 156430 (3.8%) | −324.0 | −324.0 | 3.63 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1829 / 15643 (11.7%) | 5039 / 156430 (3.2%) | −324.0 | −324.0 | 3.63 |
| Runx1 SRX1901620 | G1E Blood | 1649 / 15643 (10.5%) | 4544 / 156430 (2.9%) | −324.0 | −324.0 | 3.63 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 2312 / 15643 (14.8%) | 6371 / 156430 (4.1%) | −324.0 | −324.0 | 3.63 |
| Brd4 SRX8379041 | Macrophages Blood | 2046 / 15643 (13.1%) | 5641 / 156430 (3.6%) | −324.0 | −324.0 | 3.63 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1822 / 15643 (11.6%) | 5027 / 156430 (3.2%) | −324.0 | −324.0 | 3.62 |
| Kmt2a SRX1815514 | B cells Blood | 3266 / 15643 (20.9%) | 9025 / 156430 (5.8%) | −324.0 | −324.0 | 3.62 |
| Spi1 SRX316676 | B cells Blood | 1483 / 15643 (9.5%) | 4098 / 156430 (2.6%) | −324.0 | −324.0 | 3.62 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3653 / 15643 (23.4%) | 10128 / 156430 (6.5%) | −324.0 | −324.0 | 3.61 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 2396 / 15643 (15.3%) | 6647 / 156430 (4.2%) | −324.0 | −324.0 | 3.60 |
| Brd4 SRX8379040 | Macrophages Blood | 2025 / 15643 (12.9%) | 5621 / 156430 (3.6%) | −324.0 | −324.0 | 3.60 |
| Rnf2 SRX9633975 | B cells Blood | 2727 / 15643 (17.4%) | 7572 / 156430 (4.8%) | −324.0 | −324.0 | 3.60 |
| Batf SRX10150719 | CD8+ T cells Blood | 1490 / 15643 (9.5%) | 4142 / 156430 (2.6%) | −324.0 | −324.0 | 3.60 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2867 / 15643 (18.3%) | 7973 / 156430 (5.1%) | −324.0 | −324.0 | 3.60 |
| Batf SRX10150717 | CD8+ T cells Blood | 1863 / 15643 (11.9%) | 5185 / 156430 (3.3%) | −324.0 | −324.0 | 3.59 |
| Spi1 SRX7692793 | Eosinophils Blood | 2009 / 15643 (12.8%) | 5603 / 156430 (3.6%) | −324.0 | −324.0 | 3.59 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2722 / 15643 (17.4%) | 7593 / 156430 (4.9%) | −324.0 | −324.0 | 3.58 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2652 / 15643 (17.0%) | 7399 / 156430 (4.7%) | −324.0 | −324.0 | 3.58 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 2282 / 15643 (14.6%) | 6369 / 156430 (4.1%) | −324.0 | −324.0 | 3.58 |
| Spi1 SRX2499689 | CD25+ cells Blood | 1788 / 15643 (11.4%) | 4992 / 156430 (3.2%) | −324.0 | −324.0 | 3.58 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 2222 / 15643 (14.2%) | 6207 / 156430 (4.0%) | −324.0 | −324.0 | 3.58 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1813 / 15643 (11.6%) | 5079 / 156430 (3.2%) | −324.0 | −324.0 | 3.57 |
| Brd4 SRX884070 | MLL-AF9 leukemic cell Blood | 1759 / 15643 (11.2%) | 4928 / 156430 (3.2%) | −324.0 | −324.0 | 3.57 |
| Epitope tags SRX3219123 | RN2 Blood | 3152 / 15643 (20.1%) | 8865 / 156430 (5.7%) | −324.0 | −324.0 | 3.56 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1605 / 15643 (10.3%) | 4524 / 156430 (2.9%) | −324.0 | −324.0 | 3.55 |
| Hdac1 SRX9519543 | G1E Blood | 2404 / 15643 (15.4%) | 6781 / 156430 (4.3%) | −324.0 | −324.0 | 3.55 |
| Chd4 SRX1815523 | B cells Blood | 3292 / 15643 (21.0%) | 9289 / 156430 (5.9%) | −324.0 | −324.0 | 3.54 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2580 / 15643 (16.5%) | 7296 / 156430 (4.7%) | −324.0 | −324.0 | 3.54 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3926 / 15643 (25.1%) | 11114 / 156430 (7.1%) | −324.0 | −324.0 | 3.53 |
| Biotin SRX10950533 | B-ALL Blood | 1553 / 15643 (9.9%) | 4398 / 156430 (2.8%) | −324.0 | −324.0 | 3.53 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 2095 / 15643 (13.4%) | 5948 / 156430 (3.8%) | −324.0 | −324.0 | 3.52 |
| Spi1 SRX5026210 | Mast Cells Blood | 2551 / 15643 (16.3%) | 7246 / 156430 (4.6%) | −324.0 | −324.0 | 3.52 |
| Spi1 SRX2499720 | Scid.adh.2c2 Blood | 1567 / 15643 (10.0%) | 4468 / 156430 (2.9%) | −324.0 | −324.0 | 3.51 |
| Ikzf3 SRX10166888 | Thymocytes Blood | 1661 / 15643 (10.6%) | 4738 / 156430 (3.0%) | −324.0 | −324.0 | 3.51 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2560 / 15643 (16.4%) | 7312 / 156430 (4.7%) | −324.0 | −324.0 | 3.50 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2559 / 15643 (16.4%) | 7315 / 156430 (4.7%) | −324.0 | −324.0 | 3.50 |
| Nipbl SRX4895106 | CH12 Blood | 3005 / 15643 (19.2%) | 8606 / 156430 (5.5%) | −324.0 | −324.0 | 3.49 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1998 / 15643 (12.8%) | 5725 / 156430 (3.7%) | −324.0 | −324.0 | 3.49 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 3289 / 15643 (21.0%) | 9457 / 156430 (6.0%) | −324.0 | −324.0 | 3.48 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2571 / 15643 (16.4%) | 7397 / 156430 (4.7%) | −324.0 | −324.0 | 3.48 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1669 / 15643 (10.7%) | 4811 / 156430 (3.1%) | −324.0 | −324.0 | 3.47 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2461 / 15643 (15.7%) | 7099 / 156430 (4.5%) | −324.0 | −324.0 | 3.47 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1809 / 15643 (11.6%) | 5230 / 156430 (3.3%) | −324.0 | −324.0 | 3.46 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 3493 / 15643 (22.3%) | 10101 / 156430 (6.5%) | −324.0 | −324.0 | 3.46 |
| Nipbl SRX3753615 | B cells Blood | 2781 / 15643 (17.8%) | 8055 / 156430 (5.1%) | −324.0 | −324.0 | 3.45 |
| Runx1 SRX1892680 | 416B Blood | 1690 / 15643 (10.8%) | 4897 / 156430 (3.1%) | −324.0 | −324.0 | 3.45 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 2123 / 15643 (13.6%) | 6154 / 156430 (3.9%) | −324.0 | −324.0 | 3.45 |
| Cbfb SRX2389674 | Thymocytes Blood | 3705 / 15643 (23.7%) | 10756 / 156430 (6.9%) | −324.0 | −324.0 | 3.44 |
| Spi1 SRX340955 | FDCPmix Blood | 1704 / 15643 (10.9%) | 4948 / 156430 (3.2%) | −324.0 | −324.0 | 3.44 |
| Yy1 SRX14617670 | CH12 Blood | 2557 / 15643 (16.3%) | 7433 / 156430 (4.8%) | −324.0 | −324.0 | 3.44 |
| Stat5a SRX17605414 | Leukemia Blood | 1985 / 15643 (12.7%) | 5771 / 156430 (3.7%) | −324.0 | −324.0 | 3.44 |
| Kdm2b SRX22719876 | Leukemia Blood | 2349 / 15643 (15.0%) | 6830 / 156430 (4.4%) | −324.0 | −324.0 | 3.44 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 2353 / 15643 (15.0%) | 6855 / 156430 (4.4%) | −324.0 | −324.0 | 3.43 |
| Foxp3 SRX2341417 | Treg Blood | 2050 / 15643 (13.1%) | 5976 / 156430 (3.8%) | −324.0 | −324.0 | 3.43 |
| Pax5 SRX10950551 | Pro-B cells Blood | 2272 / 15643 (14.5%) | 6625 / 156430 (4.2%) | −324.0 | −324.0 | 3.43 |
| Cbfb SRX2389672 | Thymocytes Blood | 3811 / 15643 (24.4%) | 11119 / 156430 (7.1%) | −324.0 | −324.0 | 3.43 |
| Satb1 SRX13440924 | Thymus Blood | 2434 / 15643 (15.6%) | 7119 / 156430 (4.6%) | −324.0 | −324.0 | 3.42 |
| Med1 SRX1403504 | MLL-AF9 leukemic cell Blood | 1719 / 15643 (11.0%) | 5029 / 156430 (3.2%) | −324.0 | −324.0 | 3.42 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2865 / 15643 (18.3%) | 8383 / 156430 (5.4%) | −324.0 | −324.0 | 3.42 |
| Kdm2b SRX22719874 | Leukemia Blood | 1655 / 15643 (10.6%) | 4846 / 156430 (3.1%) | −324.0 | −324.0 | 3.42 |
| Hdac2 SRX1815527 | B cells Blood | 3380 / 15643 (21.6%) | 9909 / 156430 (6.3%) | −324.0 | −324.0 | 3.41 |
| Ep300 SRX1565831 | Natural killer cells Blood | 2370 / 15643 (15.2%) | 6970 / 156430 (4.5%) | −324.0 | −324.0 | 3.40 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 3162 / 15643 (20.2%) | 9309 / 156430 (6.0%) | −324.0 | −324.0 | 3.40 |
| Yy1 SRX14617672 | CH12 Blood | 2609 / 15643 (16.7%) | 7690 / 156430 (4.9%) | −324.0 | −324.0 | 3.39 |
| Pax5 SRX5358487 | Pro-B cells Blood | 2051 / 15643 (13.1%) | 6050 / 156430 (3.9%) | −324.0 | −324.0 | 3.39 |
| Elf1 SRX6783985 | CH12 Blood | 1584 / 15643 (10.1%) | 4674 / 156430 (3.0%) | −324.0 | −324.0 | 3.39 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2885 / 15643 (18.4%) | 8522 / 156430 (5.4%) | −324.0 | −324.0 | 3.39 |
| Ikzf1 SRX20340936 | Pre-B cells Blood | 1719 / 15643 (11.0%) | 5078 / 156430 (3.2%) | −324.0 | −324.0 | 3.39 |
| Eomes SRX4510928 | OT-1 Blood | 1694 / 15643 (10.8%) | 5007 / 156430 (3.2%) | −324.0 | −324.0 | 3.38 |
| Ep300 SRX1565832 | Natural killer cells Blood | 2233 / 15643 (14.3%) | 6604 / 156430 (4.2%) | −324.0 | −324.0 | 3.38 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1745 / 15643 (11.2%) | 5166 / 156430 (3.3%) | −324.0 | −324.0 | 3.38 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 2222 / 15643 (14.2%) | 6632 / 156430 (4.2%) | −324.0 | −324.0 | 3.35 |
| Spi1 SRX1131940 | Plasmablasts Blood | 2143 / 15643 (13.7%) | 6403 / 156430 (4.1%) | −324.0 | −324.0 | 3.35 |
| Bcl11b SRX663233 | Thymocytes Blood | 1841 / 15643 (11.8%) | 5504 / 156430 (3.5%) | −324.0 | −324.0 | 3.34 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2951 / 15643 (18.9%) | 8834 / 156430 (5.6%) | −324.0 | −324.0 | 3.34 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2771 / 15643 (17.7%) | 8297 / 156430 (5.3%) | −324.0 | −324.0 | 3.34 |
| Yy1 SRX14617701 | CH12 Blood | 2684 / 15643 (17.2%) | 8091 / 156430 (5.2%) | −324.0 | −324.0 | 3.32 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3841 / 15643 (24.6%) | 11590 / 156430 (7.4%) | −324.0 | −324.0 | 3.31 |
| Bcl11b SRX663234 | Thymocytes Blood | 1790 / 15643 (11.4%) | 5402 / 156430 (3.5%) | −324.0 | −324.0 | 3.31 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3938 / 15643 (25.2%) | 11889 / 156430 (7.6%) | −324.0 | −324.0 | 3.31 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 3416 / 15643 (21.8%) | 10314 / 156430 (6.6%) | −324.0 | −324.0 | 3.31 |
| Biotin SRX13366571 | Plasmablasts Blood | 1883 / 15643 (12.0%) | 5686 / 156430 (3.6%) | −324.0 | −324.0 | 3.31 |
| Yy1 SRX14617671 | CH12 Blood | 2746 / 15643 (17.6%) | 8294 / 156430 (5.3%) | −324.0 | −324.0 | 3.31 |
| Spi1 SRX1686485 | Bone Marrow Cells Blood | 1668 / 15643 (10.7%) | 5055 / 156430 (3.2%) | −324.0 | −324.0 | 3.30 |
| Kdm2b SRX22719877 | Leukemia Blood | 3236 / 15643 (20.7%) | 9809 / 156430 (6.3%) | −324.0 | −324.0 | 3.30 |
| Spi1 SRX2341952 | LSK cells Blood | 1922 / 15643 (12.3%) | 5829 / 156430 (3.7%) | −324.0 | −324.0 | 3.30 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 2069 / 15643 (13.2%) | 6285 / 156430 (4.0%) | −324.0 | −324.0 | 3.29 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 2068 / 15643 (13.2%) | 6293 / 156430 (4.0%) | −324.0 | −324.0 | 3.29 |
| Yy1 SRX14617700 | CH12 Blood | 2673 / 15643 (17.1%) | 8142 / 156430 (5.2%) | −324.0 | −324.0 | 3.28 |
| Smarca4 SRX1815522 | B cells Blood | 3854 / 15643 (24.6%) | 11744 / 156430 (7.5%) | −324.0 | −324.0 | 3.28 |
| Asxl1 SRX1471726 | Mesenchymal stem cells Others | 1790 / 15643 (11.4%) | 5470 / 156430 (3.5%) | −324.0 | −324.0 | 3.27 |
| Asxl1 SRX2837022 | Mesenchymal stem cells Others | 1789 / 15643 (11.4%) | 5473 / 156430 (3.5%) | −324.0 | −324.0 | 3.27 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 2013 / 15643 (12.9%) | 6159 / 156430 (3.9%) | −324.0 | −324.0 | 3.27 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 2295 / 15643 (14.7%) | 7022 / 156430 (4.5%) | −324.0 | −324.0 | 3.27 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1914 / 15643 (12.2%) | 5867 / 156430 (3.8%) | −324.0 | −324.0 | 3.26 |
| Foxp3 SRX2341414 | Treg Blood | 2052 / 15643 (13.1%) | 6303 / 156430 (4.0%) | −324.0 | −324.0 | 3.26 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1979 / 15643 (12.7%) | 6091 / 156430 (3.9%) | −324.0 | −324.0 | 3.25 |
| Chd4 SRX1815509 | B cells Blood | 2159 / 15643 (13.8%) | 6648 / 156430 (4.2%) | −324.0 | −324.0 | 3.25 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2511 / 15643 (16.1%) | 7732 / 156430 (4.9%) | −324.0 | −324.0 | 3.25 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2660 / 15643 (17.0%) | 8201 / 156430 (5.2%) | −324.0 | −324.0 | 3.24 |
| Biotin SRX13366572 | Plasmablasts Blood | 2118 / 15643 (13.5%) | 6532 / 156430 (4.2%) | −324.0 | −324.0 | 3.24 |
| Ikzf1 SRX205987 | B cells Blood | 3028 / 15643 (19.4%) | 9349 / 156430 (6.0%) | −324.0 | −324.0 | 3.24 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2990 / 15643 (19.1%) | 9246 / 156430 (5.9%) | −324.0 | −324.0 | 3.23 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3993 / 15643 (25.5%) | 12348 / 156430 (7.9%) | −324.0 | −324.0 | 3.23 |
| Max SRX9432515 | RAW 264.7 Blood | 2331 / 15643 (14.9%) | 7222 / 156430 (4.6%) | −324.0 | −324.0 | 3.23 |
| Mxi1 SRX140388 | CH12 Blood | 2482 / 15643 (15.9%) | 7699 / 156430 (4.9%) | −324.0 | −324.0 | 3.22 |
| Kdm2b SRX22719878 | Leukemia Blood | 1976 / 15643 (12.6%) | 6133 / 156430 (3.9%) | −324.0 | −324.0 | 3.22 |
| Rad21 SRX7481994 | Pro-B cells Blood | 2201 / 15643 (14.1%) | 6839 / 156430 (4.4%) | −324.0 | −324.0 | 3.22 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 3318 / 15643 (21.2%) | 10312 / 156430 (6.6%) | −324.0 | −324.0 | 3.22 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 2128 / 15643 (13.6%) | 6614 / 156430 (4.2%) | −324.0 | −324.0 | 3.22 |
| Tcf12 SRX6784087 | CH12 Blood | 1752 / 15643 (11.2%) | 5456 / 156430 (3.5%) | −324.0 | −324.0 | 3.21 |
| Spi1 SRX12298594 | B cells Blood | 2233 / 15643 (14.3%) | 6960 / 156430 (4.4%) | −324.0 | −324.0 | 3.21 |
| Spi1 SRX2499682 | CD25+ cells Blood | 2362 / 15643 (15.1%) | 7385 / 156430 (4.7%) | −324.0 | −324.0 | 3.20 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 2216 / 15643 (14.2%) | 6932 / 156430 (4.4%) | −324.0 | −324.0 | 3.20 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 2223 / 15643 (14.2%) | 6962 / 156430 (4.5%) | −324.0 | −324.0 | 3.19 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2717 / 15643 (17.4%) | 8580 / 156430 (5.5%) | −324.0 | −324.0 | 3.17 |
| Spi1 SRX340960 | FDCPmix Blood | 1813 / 15643 (11.6%) | 5727 / 156430 (3.7%) | −324.0 | −324.0 | 3.17 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3643 / 15643 (23.3%) | 11532 / 156430 (7.4%) | −324.0 | −324.0 | 3.16 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2519 / 15643 (16.1%) | 7976 / 156430 (5.1%) | −324.0 | −324.0 | 3.16 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2623 / 15643 (16.8%) | 8306 / 156430 (5.3%) | −324.0 | −324.0 | 3.16 |
| Taf1 SRX19028407 | ES cells Pluripotent stem cell | 1761 / 15643 (11.3%) | 5584 / 156430 (3.6%) | −324.0 | −324.0 | 3.15 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 2173 / 15643 (13.9%) | 6893 / 156430 (4.4%) | −324.0 | −324.0 | 3.15 |
| Ikzf1 SRX205986 | B cells Blood | 3530 / 15643 (22.6%) | 11212 / 156430 (7.2%) | −324.0 | −324.0 | 3.15 |
| Hcfc1 SRX188798 | MEL Blood | 1876 / 15643 (12.0%) | 5960 / 156430 (3.8%) | −324.0 | −324.0 | 3.15 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2373 / 15643 (15.2%) | 7539 / 156430 (4.8%) | −324.0 | −324.0 | 3.15 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 2058 / 15643 (13.2%) | 6561 / 156430 (4.2%) | −324.0 | −324.0 | 3.14 |
| Smarca4 SRX1815508 | B cells Blood | 3867 / 15643 (24.7%) | 12335 / 156430 (7.9%) | −324.0 | −324.0 | 3.13 |
| Kmt2d SRX17605389 | Granulocytic-monocytic progenitors Blood | 1872 / 15643 (12.0%) | 5972 / 156430 (3.8%) | −324.0 | −324.0 | 3.13 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 2024 / 15643 (12.9%) | 6466 / 156430 (4.1%) | −324.0 | −324.0 | 3.13 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 2063 / 15643 (13.2%) | 6592 / 156430 (4.2%) | −324.0 | −324.0 | 3.13 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2668 / 15643 (17.1%) | 8535 / 156430 (5.5%) | −324.0 | −324.0 | 3.13 |
| Cebpa SRX8005881 | Macrophages Blood | 1945 / 15643 (12.4%) | 6231 / 156430 (4.0%) | −324.0 | −324.0 | 3.12 |
| Smc1a SRX7348141 | Thymocytes Blood | 2299 / 15643 (14.7%) | 7392 / 156430 (4.7%) | −324.0 | −324.0 | 3.11 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2693 / 15643 (17.2%) | 8664 / 156430 (5.5%) | −324.0 | −324.0 | 3.11 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2833 / 15643 (18.1%) | 9149 / 156430 (5.8%) | −324.0 | −324.0 | 3.10 |
| Sp1 SRX7799921 | CH12 Blood | 1960 / 15643 (12.5%) | 6330 / 156430 (4.0%) | −324.0 | −324.0 | 3.10 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 2105 / 15643 (13.5%) | 6799 / 156430 (4.3%) | −324.0 | −324.0 | 3.10 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 2161 / 15643 (13.8%) | 6980 / 156430 (4.5%) | −324.0 | −324.0 | 3.10 |
| Brd9 SRX5689483 | nTreg Blood | 1918 / 15643 (12.3%) | 6198 / 156430 (4.0%) | −324.0 | −324.0 | 3.09 |
| Spi1 SRX5056010 | Hematopoietic progenitors Blood | 1931 / 15643 (12.3%) | 6247 / 156430 (4.0%) | −324.0 | −324.0 | 3.09 |
| Phf8 SRX2396659 | Prostate Prostate | 2142 / 15643 (13.7%) | 6942 / 156430 (4.4%) | −324.0 | −324.0 | 3.09 |
| Smc1a SRX7348142 | Thymocytes Blood | 2235 / 15643 (14.3%) | 7254 / 156430 (4.6%) | −324.0 | −324.0 | 3.08 |
| Hcfc1 SRX188815 | CH12 Blood | 2086 / 15643 (13.3%) | 6772 / 156430 (4.3%) | −324.0 | −324.0 | 3.08 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2792 / 15643 (17.8%) | 9068 / 156430 (5.8%) | −324.0 | −324.0 | 3.08 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 2380 / 15643 (15.2%) | 7745 / 156430 (5.0%) | −324.0 | −324.0 | 3.07 |
| Eomes SRX4510927 | OT-1 Blood | 2380 / 15643 (15.2%) | 7745 / 156430 (5.0%) | −324.0 | −324.0 | 3.07 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 2431 / 15643 (15.5%) | 7911 / 156430 (5.1%) | −324.0 | −324.0 | 3.07 |
| Runx1 SRX310206 | Mast Cells Blood | 3490 / 15643 (22.3%) | 11363 / 156430 (7.3%) | −324.0 | −324.0 | 3.07 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2899 / 15643 (18.5%) | 9444 / 156430 (6.0%) | −324.0 | −324.0 | 3.07 |
| Sin3a SRX188801 | CH12 Blood | 2779 / 15643 (17.8%) | 9096 / 156430 (5.8%) | −324.0 | −324.0 | 3.06 |
| Spi1 SRX392743 | HAFTL Blood | 1927 / 15643 (12.3%) | 6318 / 156430 (4.0%) | −324.0 | −324.0 | 3.05 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2845 / 15643 (18.2%) | 9343 / 156430 (6.0%) | −324.0 | −324.0 | 3.05 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 2264 / 15643 (14.5%) | 7468 / 156430 (4.8%) | −324.0 | −324.0 | 3.03 |
| Nipbl SRX8694051 | Neutrophils Blood | 2001 / 15643 (12.8%) | 6629 / 156430 (4.2%) | −324.0 | −324.0 | 3.02 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2946 / 15643 (18.8%) | 9764 / 156430 (6.2%) | −324.0 | −324.0 | 3.02 |
| Med1 SRX1403505 | MLL-AF9 leukemic cell Blood | 2210 / 15643 (14.1%) | 7350 / 156430 (4.7%) | −324.0 | −324.0 | 3.01 |
| Spi1 SRX1056343 | 416B Blood | 2737 / 15643 (17.5%) | 9110 / 156430 (5.8%) | −324.0 | −324.0 | 3.00 |
| Spi1 SRX2341954 | Hematopoietic Stem Cells Blood | 2454 / 15643 (15.7%) | 8177 / 156430 (5.2%) | −324.0 | −324.0 | 3.00 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2683 / 15643 (17.2%) | 8953 / 156430 (5.7%) | −324.0 | −324.0 | 3.00 |
| Brd4 SRX1403501 | MLL-AF9 leukemic cell Blood | 1915 / 15643 (12.2%) | 6397 / 156430 (4.1%) | −324.0 | −324.0 | 2.99 |
| Phf8 SRX2396657 | Prostate Prostate | 2263 / 15643 (14.5%) | 7568 / 156430 (4.8%) | −324.0 | −324.0 | 2.99 |
| Spi1 SRX8030788 | Acute myeloid leukemia Blood | 2319 / 15643 (14.8%) | 7756 / 156430 (5.0%) | −324.0 | −324.0 | 2.99 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2979 / 15643 (19.0%) | 9964 / 156430 (6.4%) | −324.0 | −324.0 | 2.99 |
| Spi1 SRX886478 | B-ALL Blood | 3375 / 15643 (21.6%) | 11297 / 156430 (7.2%) | −324.0 | −324.0 | 2.99 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 3365 / 15643 (21.5%) | 11285 / 156430 (7.2%) | −324.0 | −324.0 | 2.98 |
| Gfi1 SRX5131513 | Medulloblastoma Neural | 1937 / 15643 (12.4%) | 6506 / 156430 (4.2%) | −324.0 | −324.0 | 2.98 |
| Myc SRX140369 | CH12 Blood | 1874 / 15643 (12.0%) | 6304 / 156430 (4.0%) | −324.0 | −324.0 | 2.97 |
| Ep300 SRX183951 | Th1 Cells Blood | 2936 / 15643 (18.8%) | 9890 / 156430 (6.3%) | −324.0 | −324.0 | 2.97 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2621 / 15643 (16.8%) | 8838 / 156430 (5.6%) | −324.0 | −324.0 | 2.97 |
| Kmt2d SRX17605402 | Leukemia Blood | 2856 / 15643 (18.3%) | 9639 / 156430 (6.2%) | −324.0 | −324.0 | 2.96 |
| Spi1 SRX2499683 | CD25+ cells Blood | 2727 / 15643 (17.4%) | 9243 / 156430 (5.9%) | −324.0 | −324.0 | 2.95 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 3462 / 15643 (22.1%) | 11779 / 156430 (7.5%) | −324.0 | −324.0 | 2.94 |
| Spi1 SRX2499684 | CD25+ cells Blood | 2724 / 15643 (17.4%) | 9283 / 156430 (5.9%) | −324.0 | −324.0 | 2.93 |
| Spi1 SRX7368532 | B cells Blood | 2930 / 15643 (18.7%) | 9992 / 156430 (6.4%) | −324.0 | −324.0 | 2.93 |
| Nipbl SRX8693945 | Neutrophils Blood | 2302 / 15643 (14.7%) | 7854 / 156430 (5.0%) | −324.0 | −324.0 | 2.93 |
| Spi1 SRX2188529 | Pro-B cells Blood | 2585 / 15643 (16.5%) | 8831 / 156430 (5.6%) | −324.0 | −324.0 | 2.93 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2809 / 15643 (18.0%) | 9602 / 156430 (6.1%) | −324.0 | −324.0 | 2.93 |
| Hdac2 SRX1815513 | B cells Blood | 3484 / 15643 (22.3%) | 11914 / 156430 (7.6%) | −324.0 | −324.0 | 2.92 |
| Smarca4 SRX8693963 | Neutrophils Blood | 2905 / 15643 (18.6%) | 9991 / 156430 (6.4%) | −324.0 | −324.0 | 2.91 |
| Smarcb1 SRX17605375 | Leukemia Blood | 2129 / 15643 (13.6%) | 7340 / 156430 (4.7%) | −324.0 | −324.0 | 2.90 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2411 / 15643 (15.4%) | 8322 / 156430 (5.3%) | −324.0 | −324.0 | 2.90 |
| Bcl11b SRX2399084 | Thymocytes Blood | 4629 / 15643 (29.6%) | 15983 / 156430 (10.2%) | −324.0 | −324.0 | 2.90 |
| AML1-ETO SRX3491901 | Spleen Spleen | 2245 / 15643 (14.4%) | 7757 / 156430 (5.0%) | −324.0 | −324.0 | 2.89 |
| Spi1 SRX8693957 | Neutrophils Blood | 2504 / 15643 (16.0%) | 8689 / 156430 (5.6%) | −324.0 | −324.0 | 2.88 |
| Spi1 SRX742829 | Plasmacytoid dendritic cells Blood | 2155 / 15643 (13.8%) | 7479 / 156430 (4.8%) | −324.0 | −324.0 | 2.88 |
| Ctcf SRX5086076 | Th2 Cells Blood | 1964 / 15643 (12.6%) | 6819 / 156430 (4.4%) | −324.0 | −324.0 | 2.88 |
| Mxi1 SRX140391 | MEL Blood | 2621 / 15643 (16.8%) | 9108 / 156430 (5.8%) | −324.0 | −324.0 | 2.88 |
| Runx1 SRX3660775 | CD4 CD8 double negative cells Blood | 3704 / 15643 (23.7%) | 12887 / 156430 (8.2%) | −324.0 | −324.0 | 2.87 |
| Runx1 SRX3660776 | CD4 CD8 double negative cells Blood | 3626 / 15643 (23.2%) | 12616 / 156430 (8.1%) | −324.0 | −324.0 | 2.87 |
| Runx1 SRX3195539 | CD4 CD8 double negative cells Blood | 3623 / 15643 (23.2%) | 12606 / 156430 (8.1%) | −324.0 | −324.0 | 2.87 |
| Runx1 SRX3195537 | CD4 CD8 double negative cells Blood | 3701 / 15643 (23.7%) | 12896 / 156430 (8.2%) | −324.0 | −324.0 | 2.87 |
| Chd4 SRX3660752 | CD4 CD8 double negative cells Blood | 2964 / 15643 (18.9%) | 10340 / 156430 (6.6%) | −324.0 | −324.0 | 2.87 |
| Hdac2 SRX3660759 | CD4 CD8 double negative cells Blood | 3336 / 15643 (21.3%) | 11663 / 156430 (7.5%) | −324.0 | −324.0 | 2.86 |
| Spi1 SRX1630945 | Granulocytic-monocytic progenitors Blood | 2048 / 15643 (13.1%) | 7190 / 156430 (4.6%) | −324.0 | −324.0 | 2.85 |
| Nfib SRX19694892 | C3H/10T1/2 Embryonic fibroblast | 2507 / 15643 (16.0%) | 8824 / 156430 (5.6%) | −324.0 | −324.0 | 2.84 |
| Max SRX140371 | CH12 Blood | 2218 / 15643 (14.2%) | 7808 / 156430 (5.0%) | −324.0 | −324.0 | 2.84 |
Showing first 500 of 11856 rows.